Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent
US7144587B2 · kind B2 · utility
194Cited by
6References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 6, 2002 |
| Grant date | Dec 5, 2006 |
| Priority date | — |
| Expiry date | Sep 22, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and a bittering agent in an effective amount to impart a bitter taste to an abuser upon administration of the dosage form after tampering.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.